| Code | 8369C | ||||||||||
| MA number | 29/0211/18-S | ||||||||||
| Product Form: | tbl 120x200 mg (fľ.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Egis Pharmaceuticals PLC, Hungary | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | brown glass bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 04.07.2018 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Milurit 150mg, 200mg_12.2024.pdf
|
| SPC: |
SPC_Milurit 150mg, 200mg_12.2024.pdf
|
| Safety feature | Yes |
| Data update: | 15.04.2024 |
